Comprehensive Reverse Shoulder Data Collection

Status Enrolling by invitation

Clinical Trial Summary

This study is a multicenter, prospective, non-randomized, non-controlled clinical outcome study. The primary objective of this study is to evaluate improvement of pain score at one year for the Biomet Comprehensive Reverse Shoulder. The secondary objective is collection of long term clinical outcomes.

Clinical Trial Description

The Biomet Comprehensive Reverse Shoulder was developed to provide an additional surgical option for patients anatomically and structurally suited to receive a reverse shoulder arthroplasty. The aim of the Biomet Comprehensive Reverse Shoulder is to increase shoulder function while reducing pain. This is a multi-center study. Having several clinical sites will allow for multiple investigators to contribute to the results of the study. 175 implants will be included into the study. All potential study subjects will be required to participate in the Informed Consent Process. ;

Study Design

Related Conditions & MeSH terms

Arthropathy of Shoulder Region
Grossly Deficient Rotator Cuff
Joint Diseases
Osteoarthritis
Osteoarthritis of the Shoulder
Post-Traumatic Arthitis
Rheumatoid Arthritis Without Humeral Metaphyseal Defects

Clinical Trial Details

NCT number	NCT03404778
Study type	Observational
Source	Zimmer Biomet
Contact
Status	Enrolling by invitation
Phase
Start date	March 7, 2010
Completion date	December 2034

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05160441` - Comparing Platelet Rich Plasma and Corticosteroid for Military & Civilian Patients With Glenohumeral Osteoarthritis	Phase 3
Active, not recruiting	`NCT02204228` - TITAN™ Reverse Shoulder System
Recruiting	`NCT04468178` - Clinical Results and RSA Migration Analysis of the GLOBAL ICON - Stemless Anatomic Shoulder	N/A
Withdrawn	`NCT03770546` - Amnion-Based Injections in the Shoulder	N/A
Active, not recruiting	`NCT05049993` - Pyrocarbon Clinical Follow-up Study
Terminated	`NCT04160091` - Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis	Phase 2
Completed	`NCT00479687` - SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder	N/A
Recruiting	`NCT04228419` - TSA vs RSA in Glenohumeral Osteoarthritis	N/A
Completed	`NCT02052206` - Reconstruction of Complex Proximal Humeral Fractures.	N/A
Completed	`NCT03887650` - LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs	Phase 4
Active, not recruiting	`NCT04634773` - Unravelling the Etiology of Shoulder Osteoarthritis	N/A
Completed	`NCT01697865` - Reverse Shoulder Arthroplasty With or Without Concomitant Latissimus and Teres Major Transfer for Shoulder Pseudoparalysis With Teres Minor Dysfunction	N/A
Enrolling by invitation	`NCT03806881` - Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant
Active, not recruiting	`NCT01587560` - A Comparison Between a Pyrocarbon and a CoCr Shoulder Resurfacing Implant	N/A
Completed	`NCT03385408` - Effectiveness of HILT in Shoulder Osteoarthritis	N/A
Active, not recruiting	`NCT03097406` - Functional Outcome and Complications After Global Unite ® Prostheses
Active, not recruiting	`NCT03409718` - Database Retrieval for the Comprehensive Shoulder
Withdrawn	`NCT04134442` - Improving Pain Management After Total Shoulder Replacement Using Bupivacaine Liposome	Phase 4
Completed	`NCT03382262` - Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip	Phase 2
Active, not recruiting	`NCT03726554` - Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty	N/A